Veradigm | MDRX - Actif À Court Terme





Actif À Court Terme Changement Date
Alcidion AUD 28.52M 4.83M 2025-12
Ambu A/S DKK 3.05B 111M 2025-12
Amplifon EUR 441.88M 238.03M 2025-09
Cardinal Health USD 39.23B 693M 2025-12
Centene USD 40.37B 3.69B 2025-12
Charles River Laboratories USD 1.45B 85.06M 2025-12
Cigna USD 47.81B 1.08B 2025-12
Coloplast 10.3B 155M 2025-12
Computer Programs Systems USD 104.64M 2.07M 2025-12
Convatec Group USD 793.3M 70.6M 2024-12
CVS Health USD 74.71B 2.4B 2025-12
Diasorin EUR 759.63M 400.63M 2025-06
Elevance Health USD 63B 777M 2025-12
General Electric Aerospace USD 40.36B 235M 2026-03
Gulf Medical Proj AED 431.22M 55.83M 2025-12
Humana USD 32.73B 19M 2025-12
IQVIA Holdings USD 6.25B 270M 2025-12
Laboratory Of America USD 4.02B 58.3M 2025-12
Maximus USD 1.42B 170.28M 2025-12
McKesson USD 59.7B 190M 2025-12
Med Life RON 695.45M 10.09M 2025-12
Molina Healthcare USD 12.44B 108M 2025-12
Omnicell USD 680.07M 20.45M 2025-12
Oriola-kd EUR 656.9M 42.9M 2025-12
Owens Minor USD 547.87M 1.58B 2025-12
Quest Diagnostics USD 2.38B 29M 2025-12
Rede D'or Sao Luiz BRL 53.78B 4.28B 2025-12
Siemens Healthineers EUR 14.19B 96M 2025-12
Sonova Holding CHF 1.91B 466.3M 2025-06
Supermax Corporation Bhd MYR 1.08B 116.24M 2025-12
UnitedHealth USD 95.07B 1.37B 2025-09
Veeva Systems USD 8B 885.78M 2025-12
Veradigm USD 679.65M 131.12M 2022-12
Xerox USD 3.75B 210M 2025-09